143 related articles for article (PubMed ID: 12488488)
1. The immune system and prion diseases: a relationship of complicity and blindness.
Aucouturier P; Carnaud C
J Leukoc Biol; 2002 Dec; 72(6):1075-83. PubMed ID: 12488488
[TBL] [Abstract][Full Text] [Related]
2. Cells and prions: a license to replicate.
Nuvolone M; Aguzzi A; Heikenwalder M
FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722
[TBL] [Abstract][Full Text] [Related]
3. Prion diseases and the immune system.
Aucouturier P; Carp RI; Carnaud C; Wisniewski T
Clin Immunol; 2000 Aug; 96(2):79-85. PubMed ID: 10900153
[TBL] [Abstract][Full Text] [Related]
4. [Involvement of the immunological system in the pathogenesis of transmissible spongiform encephalopathies].
Brun A; Castilla J; Parra B; Rodríguez F; Torres JM
Rev Neurol; 2003 Oct 1-15; 37(7):648-53. PubMed ID: 14582023
[TBL] [Abstract][Full Text] [Related]
5. Prion diseases and the immune system.
Aucouturier P; Frangione B; Wisniewski T
Ann Med Interne (Paris); 1999 Feb; 150(2):75-8. PubMed ID: 10392254
[TBL] [Abstract][Full Text] [Related]
6. Germinal center B cells are dispensable in prion transport and neuroinvasion.
Heikenwalder M; Federau C; Boehmer Lv; Schwarz P; Wagner M; Zeller N; Haybaeck J; Prinz M; Becher B; Aguzzi A
J Neuroimmunol; 2007 Dec; 192(1-2):113-23. PubMed ID: 17964667
[TBL] [Abstract][Full Text] [Related]
7. Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases.
Tayebi M; Hawke S
Immunol Lett; 2006 Jun; 105(2):123-6. PubMed ID: 16621033
[TBL] [Abstract][Full Text] [Related]
8. Prion diseases: from molecular biology to intervention strategies.
Nunziante M; Gilch S; Schätzl HM
Chembiochem; 2003 Dec; 4(12):1268-84. PubMed ID: 14661267
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells and oral transmission of prion diseases.
Huang FP; MacPherson GG
Adv Drug Deliv Rev; 2004 Apr; 56(6):901-13. PubMed ID: 15063597
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in mucosal vaccines against prion diseases.
Sakaguchi S; Arakawa T
Expert Rev Vaccines; 2007 Feb; 6(1):75-85. PubMed ID: 17280480
[TBL] [Abstract][Full Text] [Related]
11. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
[TBL] [Abstract][Full Text] [Related]
12. Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion.
Ishibashi D; Yamanaka H; Yamaguchi N; Yoshikawa D; Nakamura R; Okimura N; Yamaguchi Y; Shigematsu K; Katamine S; Sakaguchi S
Vaccine; 2007 Jan; 25(6):985-92. PubMed ID: 17055125
[TBL] [Abstract][Full Text] [Related]
13. Antibody-based immunotherapeutic attempts in experimental animal models of prion diseases.
Sakaguchi S; Ishibashi D; Matsuda H
Expert Opin Ther Pat; 2009 Jul; 19(7):907-17. PubMed ID: 19514955
[TBL] [Abstract][Full Text] [Related]
14. [When prions use the systems of communication between the immune system and the peripheral nervous system].
Dorban G; Antoine N; Defaweux V
Med Sci (Paris); 2010; 26(6-7):610-4. PubMed ID: 20619163
[TBL] [Abstract][Full Text] [Related]
15. Immunisation strategies against prion diseases: prime-boost immunisation with a PrP DNA vaccine containing foreign helper T-cell epitopes does not prevent mouse scrapie.
Nitschke C; Flechsig E; van den Brandt J; Lindner N; Lührs T; Dittmer U; Klein MA
Vet Microbiol; 2007 Aug; 123(4):367-76. PubMed ID: 17499458
[TBL] [Abstract][Full Text] [Related]
16. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
Cronier S; Laude H; Peyrin JM
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
[TBL] [Abstract][Full Text] [Related]
17. Rodent models for prion diseases.
Groschup MH; Buschmann A
Vet Res; 2008; 39(4):32. PubMed ID: 18284909
[TBL] [Abstract][Full Text] [Related]
18. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
[TBL] [Abstract][Full Text] [Related]
19. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
20. Prions: protein aggregation and infectious diseases.
Aguzzi A; Calella AM
Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
